The t(14;18) in diffuse large B-cell lymphoma: Correlation with germinal center-associated markers and clinical features

Yin Xu, Robert W McKenna, Jeffrey E. Doolittle, Christa L. Hladik, Steven H. Kroft

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The clinical and biologic relevance of the t(14;18) and features of germinal center (GC) differentiation in diffuse large B-cell lymphoma (DLBCL) remain controversial. The authors examined the association of t(14;18) with GC-associated markers and clinical features in 44 de novo DLBCLs (22 nodal and 22 primary extranodal). CD10, bcl-2, and bcl-6 were expressed in 50%, 62%, and 54% of cases respectively. There were no significant differences in expression of these markers between nodal and extranodal cases. Coexpression of CD10 and bcl-6 was seen in 12 of 41 cases, and was more frequent in nodal than extranodal DLBCL (9 of 21 vs. 3 of 20; P = 0.05). A CD10(+)/bcl-6(+) phenotype was not significantly associated with bcl-2 expression, stage, complete remission rate, or survival. The t(14;18) was found in 7 of 44 (16%) cases (6 nodal, 1 extranodal; P = 0.09). It was associated with a CD10(+)/bcl-6(+) phenotype (5 of 7 vs. 7 of 27; P = 0.015) and a trend toward more frequent bcl-6 expression (6 of 7 vs. 15 of 34; P = 0.09), but no association with bcl-2 expression, CD10, clinical stage, complete remission, or survival. Among nodal or high-stage (III-IV) DLBCL, cases with the t(14;18) showed a trend toward decreased survival (P = 0.12).

Original languageEnglish (US)
Pages (from-to)116-123
Number of pages8
JournalApplied Immunohistochemistry and Molecular Morphology
Volume13
Issue number2
DOIs
StatePublished - Jun 1 2005

Keywords

  • CD10
  • Diffuse large B-cell lymphoma
  • bcl-2
  • bcl-2 translocation
  • bcl-6

Fingerprint Dive into the research topics of 'The t(14;18) in diffuse large B-cell lymphoma: Correlation with germinal center-associated markers and clinical features'. Together they form a unique fingerprint.

  • Cite this